| Literature DB >> 35966329 |
Rui Zhang1, Qin Wang1, Chao Sun1, Lijuan Niu1.
Abstract
Background: When sonographic suspicious malignant thyroid nodules initially proven to be inconsistent by aspiration, repeat fine-needle aspiration cytology (FNAC) is commonly recommended. Although FNAC is simple and reliable, it is also an invasive operation with inevitable false negative results. To determine which sonographic features and histogram parameters based on gray-scale ultrasonic images need repeat aspiration.Entities:
Keywords: Ultrasound (US); histogram analysis; thyroid
Year: 2022 PMID: 35966329 PMCID: PMC9372258 DOI: 10.21037/tcr-22-479
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 0.496
Figure 1Diagram of study selection. US, ultrasound; FNAC, fine-needle aspiration cytology.
Figure 2A 33-year-old woman with a 1.3-cm-diameter suspicious malignant thyroid nodule. (A) Transverse US image showed irregular margins, taller-than-wide shape and microcalcifications. (B) Regions of interest was manually circumscribed along the boundary of the nodule. (C) Graphs show the corresponding histogram analysis. Initial cytological finding was Bethesda category III. The final diagnosis after surgery was a papillary carcinoma. US, ultrasound.
Comparison of clinical and ultrasonographic features among the benign and malignant groups
| Variables | Total (n=123) | Postoperative histopathology | P value | |
|---|---|---|---|---|
| Benign (n=45) | Malignant (n=78) | |||
| Age at diagnosis (years) | 0.385 | |||
| Range | 22–75 | 24–45 | 22–75 | |
| Median | 46 | 48 | 45 | |
| Sex | 0.475 | |||
| Female | 92 (74.8) | 32 (71.1) | 60 (76.9) | |
| Male | 31 (25.2) | 13 (28.9) | 18 (23.1) | |
| Nodule size (cm) | 0.002 | |||
| <2 | 86 (69.9) | 24 (53.3) | 62 (79.5) | |
| ≥2 | 37 (30.1) | 21 (46.7) | 16 (20.5) | |
| Echogenicity | 0.052 | |||
| Hypoechogenicity | 113 (91.9) | 38 (84.4) | 75 (96.2) | |
| Non-hypoechogenicity | 10 (8.1) | 7 (15.6) | 3 (3.8) | |
| Margins | <0.001 | |||
| Irregular | 104 (84.6) | 28 (62.2) | 76 (97.4) | |
| Regular | 19 (15.4) | 17 (37.8) | 2 (2.6) | |
| Shape | <0.001 | |||
| Parallel | 32 (26.0) | 26 (57.8) | 6 (7.7) | |
| Taller-than-wide | 91 (74.0) | 19 (42.2) | 72 (92.3) | |
| Calcifications | <0.001 | |||
| Microcalcifications | 42 (34.1) | 4 (8.9) | 38 (48.7) | |
| Non-microcalcifications | 81 (65.9) | 41 (91.1) | 40 (51.3) | |
| Focus | 0.155 | |||
| Unifocal | 15 (12.2) | 3 (6.7) | 12 (15.4) | |
| Multifocal | 108 (87.8) | 42 (93.3) | 66 (84.6) | |
| Sonography evidence of ETE | 0.309 | |||
| Yes | 4 (3.3) | 0 | 4 (5.1) | |
| No | 119 (96.7) | 45 (100.0) | 74 (94.9) | |
| Combined with HT | 0.045 | |||
| Yes | 32 (26.0) | 7 (15.6) | 25 (32.1) | |
| No | 91 (74.0) | 38 (84.4) | 53 (67.9) | |
Data in parentheses are percentages. ETE, extrathyroidal extension; HT, Hashimoto’s thyroiditis.
Comparison of histogram parameters among the benign and malignant groups
| Variables | Benign (n=45) | Malignant (n=78) | P value |
|---|---|---|---|
| Mean | 75.408 (62.038, 96.146) | 51.788 (37.103, 59.307) | <0.001 |
| Variance | 358.020 (274.780, 455.335) | 415.240 (275.908, 690.262) | 0.171 |
| Skewness | 0.231±0.559 | 0.783±0.505 | <0.001 |
| Kurtosis | 0.183 (−0.352, 1.108) | 0.777 (0.058, 2.361) | 0.011 |
| Percentile 1% | 37.000 (23.500, 48.000) | 11.000 (1.000, 22.250) | <0.001 |
| Percentile 10% | 54.380±21.490 | 24.100±16.715 | <0.001 |
| Percentile 50% | 76.000 (56.500, 97.000) | 49.000 (35.750, 57.000) | <0.001 |
| Percentile 90% | 103.000 (87.500, 125.000) | 77.000 (65.250, 91.500) | <0.001 |
| Percentile 99% | 128.310±31.284 | 114.33±35.585 | 0.030 |
Data in accordance with normal distribution are expressed by average ± standard deviation. Data that do not conform to the normal distribution are expressed by the median (25th percentile, 75th percentile).
Multivariate logistic regression analysis of valuable features
| Variables | OR (95% CI) | P value |
|---|---|---|
| Nodule size ≥2 cm | 2.002 (0.423–9.482) | 0.382 |
| Hypoechogenicity | 2.766 (0.398–19.248) | 0.304 |
| Irregular margins | 11.492 (1.747–75.573) | 0.011 |
| Taller-than-wide shape | 15.165 (3.157–72.854) | 0.001 |
| Microcalcifications | 5.107 (1.455–17.927) | 0.011 |
| Combined with HT (yes) | 1.590 (0.479–5.284) | 0.449 |
| Mean | 0.662 (0.137–3.200) | 0.608 |
| Skewness | 25.800 (1.034–76.422) | 0.049 |
| Kurtosis | 0.542 (0.216–1.360) | 0.192 |
| Percentile 1% | 0.996 (0.823–1.126) | 0.637 |
| Percentile 10% | 0.868 (0.574–1.315) | 0.505 |
| Percentile 50% | 1.593 (0.664–3.823) | 0.297 |
| Percentile 90% | 0.980 (0.673–1.428) | 0.917 |
| Percentile 99% | 1.047 (0.933–1.175) | 0.431 |
OR, odds ratio; CI, confidence interval; HT, Hashimoto’s thyroiditis.
Figure 3ROC curve and corresponding AUCs of three traditional US characteristics skewness and for prediction of malignance. ROC, receiver operator characteristic; AUCs, areas under the curve; US, ultrasound.
Diagnostic performance of the four risk indicators
| Variables | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | AUC (95% CI) |
|---|---|---|---|---|---|
| Irregular margins | 0.974 (0.902–0.995) | 0.378 (0.242–0.535) | 0.731 (0.633–0.811) | 0.895 (0.655–0.982) | 0.676 (0.570–0.782) |
| Taller-than-wide shape | 0.923 (0.834–0.968) | 0.578 (0.422–0.720) | 0.791 (0.691–0.867) | 0.813 (0.630–0.921) | 0.750 (0.653–0.848) |
| Microcalcifications | 0.487 (0.373–0.602) | 0.911 (0.779–0.971) | 0.905 (0.765–0.969) | 0.506 (0.394–0.618) | 0.530 (0.424–0.637) |
| Skewness | 0.936 (0.850–0.976) | 0.489 (0.339–0.640) | 0.760 (0.660–0.839) | 0.815 (0.613–0.930) | 0.776 (0.689–0.862) |
CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the curve.